Literature DB >> 15004500

Ocular melanoma: epidemiology, clinical presentation and relationship with dysplastic nevi.

E Richtig1, G Langmann, K Müllner, J Smolle.   

Abstract

PURPOSE: Ocular melanoma is a rare entity compared to cutaneous malignant melanoma. We examined the frequency of the tumor in a defined geographic region, its clinical presentation and its relationship with dysplastic nevi in 136 patients.
METHODS: 136 patients (64 men and 72 women; mean age 61.7 years, range 20-92 years) with ocular melanoma were treated at the University Hospital of Graz between June 1996 and December 2001. 129 had primary uveal melanoma in one eye (117 choroidal melanomas, 11 melanomas of the ciliary body and 1 of the iris), 2 patients had uveal melanoma in both eyes, 4 patients had conjunctival melanoma and 1 patient had a melanoma of the lacrimal sac. Epidemiology, history, potential risk factors, clinical presentation and relationship with dysplastic (= atypical) nevi were documented.
RESULTS: 48 patients (35.3%) showed more than five dysplastic nevi, compared to only 1.2% in the general population (chi(2) test: p < 0.001). 5 (3.7%) had additional cutaneous melanoma and 7 (5.1%) had a family history of melanoma. The lifelong risk for the occurrence of an additional primary cutaneous melanoma was 2.9%, which is significantly higher than the usual estimate of 1% for the general population.
CONCLUSIONS: Patients with primary ocular melanoma have an increased risk to develop cutaneous melanoma and should therefore be examined regularly by dermatologists. Copyright 2004 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2004        PMID: 15004500     DOI: 10.1159/000076146

Source DB:  PubMed          Journal:  Ophthalmologica        ISSN: 0030-3755            Impact factor:   3.250


  6 in total

1.  GWAS findings for human iris patterns: associations with variants in genes that influence normal neuronal pattern development.

Authors:  Mats Larsson; David L Duffy; Gu Zhu; Jimmy Z Liu; Stuart Macgregor; Allan F McRae; Margaret J Wright; Richard A Sturm; David A Mackey; Grant W Montgomery; Nicholas G Martin; Sarah E Medland
Journal:  Am J Hum Genet       Date:  2011-08-12       Impact factor: 11.025

2.  Primary malignant melanoma of lacrimal sac.

Authors:  Min Ren; Ji-Hong Zeng; Qing-Li Luo; Feng Bi; Jun Chen
Journal:  Int J Ophthalmol       Date:  2014-12-18       Impact factor: 1.779

Review 3.  Nanomedicine in the application of uveal melanoma.

Authors:  Shuo You; Jing Luo; Hans E Grossniklaus; Ma-Ling Gou; Ke Meng; Qing Zhang
Journal:  Int J Ophthalmol       Date:  2016-08-18       Impact factor: 1.779

4.  Primary malignant melanoma of the lacrimal sac: a case report.

Authors:  Ji Hyung Nam; Seung Min Kim; Jae Hyeuk Choi; Yong Kuk Lee; Jin Ho Baek; Tae Jung Jang; Keon Uk Park
Journal:  Korean J Intern Med       Date:  2006-12       Impact factor: 2.884

5.  Primary malignant melanoma of the lacrimal sac.

Authors:  Yang-Jun Li; Shao-Jun Zhu; Hong Yan; Jing Han; Dan Wang; Shuang Xu
Journal:  BMJ Case Rep       Date:  2012-08-13

6.  Differences in Uveal Melanoma Age-Standardized Incidence Rates in Two Eastern States of Australia Are Driven by Differences in Rurality and Ultraviolet Radiation.

Authors:  Melissa Chalada; Charmaine A Ramlogan-Steel; Bijay P Dhungel; Amanda Y Goh; Samuel Gardiner; Christopher J Layton; Jason C Steel
Journal:  Cancers (Basel)       Date:  2021-11-23       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.